SION
Sionna Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.84 / 10
Outperform
Analyst sentiment is highly bullish: 66.7% Strong Buy, 33.3% Buy, with three analysts rating the stock positively. Fund‑flow metrics are excellent (score 8.0, all size categories showing positive inflows). JPMorgan’s recent stake cut is a minor negative note.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
33%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-02-24
InstitutionCitizens
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for SION?
- SION holds a Bullish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.84/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
